USA: A new study published in the Journal of Diabetes and Its Complications suggests that tirzepatide, a novel dual ...

Over the course of two months and 12 treatments, 32 study participants ages 41 to 78 self-treated with the radio waves. Outcomes were evaluated using a questionnaire. One month after treatment, 28 ...

Researchers in the U.K. found that men prescribed erectile dysfunction drugs were 18% less likely to develop Alzheimer’s disease years later. Alzheimer’s Association Dr. Ozama Ismail weighed in.

UTMB Health study says erectile dysfunction meds associated with reductions — but not where you might think 😅 Ahmed Humble , Digital Content Producer Published: November 19, 2024 at 11:38 AM ...

Tirzepatide, the active ingredient in the diabetes drug Mounjaro, helped people lose more than 60 pounds (lb), or at least one-quarter of their body weight, when used along with intensive ...

The study followed over 269,000 participants for five years, and those who were prescribed erectile dysfunction drugs were 18% less likely to develop Alzheimer’s than those who weren’t.

Tirzepatide and injectable semaglutide were associated with the greatest weight loss after a year of treatment among several GLP-1 receptor agonists, a recent study showed.“Despite being the ...

A recent study conducted on medical students by Peruvian researchers found that there may be a link between a chronic gastrointestinal disorder and erectile dysfunction (ED).. The study, published ...

NEW YORK, Feb. 7 (UPI) --Medications that treat erectile dysfunction may be tied to a lower risk of Alzheimer's disease, a new study indicates. The study was published Wednesday in the online ...